Evommune, Inc. (Nasdaq: EVMN) is a clinical-stage biopharmaceutical company headquartered in Palo Alto, California, discovering and developing therapies that target the key drivers of chronic inflammatory disease. Founded in 2020 by the team behind Dermira, the company applies a human tissue-based translational approach to immunology and is advancing a clinical pipeline that includes EVO756, an oral small-molecule MRGPRX2 antagonist in Phase 2b development for chronic spontaneous urticaria and migraine prophylaxis, and an IL-18 binding protein fusion program licensed from AprilBio. Evommune publishes no developer program, no public API and no machine-readable API contract; its public web presence is a WordPress marketing site plus a hosted investor-relations portal.
Evommune is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Immunology.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/evommune: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: evommune
name: Evommune
description: 'Evommune, Inc. (Nasdaq: EVMN) is a clinical-stage biopharmaceutical company headquartered in Palo Alto, California,
discovering and developing therapies that target the key drivers of chronic inflammatory disease. Founded in 2020 by the
team behind Dermira, the company applies a human tissue-based translational approach to immunology and is advancing a clinical
pipeline that includes EVO756, an oral small-molecule MRGPRX2 antagonist in Phase 2b development for chronic spontaneous
urticaria and migraine prophylaxis, and an IL-18 binding protein fusion program licensed from AprilBio. Evommune publishes
no developer program, no public API and no machine-readable API contract; its public web presence is a WordPress marketing
site plus a hosted investor-relations portal.'
deliveryModel:
model: saas
open_source: false
commercial: true
callable_host: false
label: Hosted service · you call their endpoint
confidence: medium
source:
- pricing
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://www.evommune.com/wp-content/uploads/2023/12/Evommune-blue-logo.svg
url: https://raw.githubusercontent.com/api-evangelist/evommune/refs/heads/main/apis.yml
x-api-posture: no-product-api
x-api-posture-basis: observed
x-api-posture-note: Evommune publishes no developer program, no public API and no machine-readable API contract; its public
web presence is a WordPress marketing site plus a hosted investor-relations portal.
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: no-api-surface
specificationVersion: '0.23'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Immunology
- Drug Development
- Clinical Trials
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://www.evommune.com/
- type: About
url: https://www.evommune.com/about-us/
- type: Contact
url: https://www.evommune.com/contact/
- type: PrivacyPolicy
url: https://www.evommune.com/wp-content/uploads/2023/12/Evommune_privacy-statement_for_website.pdf
- type: TermsOfService
url: https://www.evommune.com/wp-content/uploads/2023/12/Evommune_privacy-statement_for_website.pdf
- type: InvestorRelations
url: https://ir.evommune.com/
- type: PressReleases
url: https://ir.evommune.com/news-events/press-releases
- type: Careers
url: https://www.evommune.com/job-openings/
- type: LinkedIn
url: https://www.linkedin.com/company/evommune/
- type: Pipeline
url: https://www.evommune.com/development-pipeline/
- type: Publications
url: https://www.evommune.com/publications-posters/
- type: DomainSecurity
url: security/evommune-domain-security.yml
- type: LLMsTxt
url: llms/evommune-llms.txt
- type: SecondaryMarket
url: https://forgeglobal.com/evommune_stock/
x-enrichment:
date: '2026-08-12'
status: minimal
artifacts_added: 3
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: 'Evommune is a clinical-stage biopharmaceutical company (Nasdaq: EVMN) whose entire public surface is a WordPress
marketing site and a hosted investor-relations portal — there is no developer section, no GitHub organization, no package
on any registry, and every OpenAPI/GraphQL/MCP/agent-card path probed on both hosts returned 404; the only HTTP 200 API-shaped
response is the stock WordPress REST API at /wp-json/, which is default CMS infrastructure rather than a product Evommune
publishes.'
evidence:
- url: https://www.evommune.com/openapi.json
status: 404
- url: https://www.evommune.com/.well-known/agent-card.json
status: 404
- url: https://ir.evommune.com/llms.txt
status: 404
- url: https://api.github.com/orgs/evommune
status: 404
- url: https://www.evommune.com/wp-json/
status: 200
checked: '2026-08-12'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →